๐Ÿ›๏ธ Verified NIH Record โ€ข Updated 2026-06-18

Bi-lateral HGN Therapy in Real-World Patients -Post Approval Research Investigation (NCT07331285)

๐ŸŸข Recruiting Interventional Protocol ๐Ÿ“Š Observational Clinical Research Sponsor: Nyxoah Inc.

๐Ÿฉบ Plain-English Summary (8th-Grade Level)

The objective of the BREATHE study is to demonstrate the continued safety and effectiveness of the Genioยฎ System in treating subjects diagnosed with moderate to severe obstructive sleep apnea (OSA) who are intolerant to or failed/refused PAP treatments.

Who can join: Review the eligibility criteria below.

Location: PharmaDev Clinical Research Institute, LLC โ€” Miami, Florida

Age range: 22 Years

๐Ÿ“‹ "Do I Qualify?" โ€” 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria โ†—

๐Ÿ“ All Participating Trial Locations (2 Sites)

  • PharmaDev Clinical Research Institute, LLC โ€” Miami, Florida
  • Nyxoah, Inc โ€” Summit, New Jersey

๐Ÿ“ž Contact the Study Coordinator

Phone: (908) 263-0228

Email: clinical.studies@nyxoah.com

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

๐Ÿ’ฐ Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

๐Ÿ’ก How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Contact the study coordinator using the phone/email above.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
๐Ÿ›๏ธ View Official NIH Record โ†—